Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate Human Immunodeficiency Virus Type 1 vaccines.
Mascola, John R.
Hahn, Beatrice H.
Haigwood, Nancy L.
Petropoulos, Christos J.
Polonis, Victoria R.
Montefiori, David C.
MetadataShow full item record
No abstract available.
Showing items related by title, author, creator and subject.
Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. Gray, Glenda E.; Allen, Mary.; Moodie, Zoe.; Churchyard, Gavin J.; Bekker, Linda-Gail.; Nchabeleng, Maphoshane.; Mlisana, Koleka Patience.; Metch, Barbara.; De Bruyn, Guy.; Latka, Mary H.; Roux, Surita.; Mathebula, Matsontso.; Naicker, Nivashnee.; Ducar, Constance.; Carter, Donald K.; Puren, Adrien.; Eaton, Niles.; McElrath, M. Julie.; Robertson, Michael.; Corey, Lawrence.; Kublin, James. (Elsevier., 2011)Background. The MRKAd5 HIV-1 gag/pol/nef subtype B vaccine was designed to elicit T-cell-mediated immune responses capable of providing complete or partial protection from HIV-1 infection or a decrease in viral load after ...
Testing for passive transfer of immunity in foals, and an evaluation of the African horse sickness vaccination schedule. Crow, Linnet Jean Isobel. (2005)This thesis comprises an introductory review of the literature, followed by reports of two experiments which are presented in the form of scientific papers. For this reason, there may be some repetition between chapters, ...
An exploratory study of students' understandings and experiences of vaccination : implications for future HIV vaccine trials in South Africa. Masina, Liziwe N. V. (2004)As Africa faces the challenges of its renewal or renaissance, the HIV/AIDS epidemic poses the greatest potential barrier to the attainment of this vision (Makgoba, 2001 in Dorrington, Bourne, Bradshaw, Laubscher & Timaeus, ...